Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as a percentage of revenue in the same period.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.8% | 36.8% | 32.3% | 27.2% | 39.4% | 16.8% | 140.0% | 376.2% | 23.6% | 98.3% | 108.7% | 62.9% | |
| 73.2% | 63.2% | 67.7% | 72.8% | 60.6% | 83.2% | -40.0% | -276.2% | 76.4% | 1.7% | -8.7% | 37.1% | |
| 82.0% | 85.0% | 58.7% | 62.0% | 252.0% | 123.2% | 123.2% | 336.0% | 175.3% | 780.9% | 1,352.1% | 413.7% | |
| 88.5% | 62.8% | 74.5% | 63.3% | 85.8% | 315.2% | 286.6% | 519.5% | 178.4% | 649.2% | 1,052.1% | 724.2% | |
| 170.5% | 147.8% | 133.3% | 125.3% | 337.8% | 353.0% | 229.8% | 368.2% | 357.9% | 1,604.2% | 3,431.5% | 1,137.8% | |
| -97.3% | -84.6% | -65.6% | -59.7% | -314.9% | -269.8% | -269.8% | -644.5% | -281.4% | -1,602.5% | -3,440.2% | -1,100.8% | |
| 0.9% | 0.7% | 0.5% | 0.3% | 5.3% | 56.9% | 57.5% | 131.5% | 25.2% | 7.5% | 0.2% | 39.9% | |
| -119.2% | -50.1% | -101.7% | -56.2% | -333.9% | -326.7% | -326.7% | -777.8% | -297.2% | -1,548.0% | -3,261.9% | -2,588.2% | |
| -0.1% | 0.6% | -2.0% | -1.2% | -13.4% | -0.3% | -0.3% | -1.1% | -0.7% | -7.4% | -45.7% | 0.0% | |
| -113.8% | -48.7% | -97.7% | -50.7% | -317.2% | -533.0% | -533.0% | -646.0% | 105.2% | -1,540.6% | -3,216.2% | -2,588.2% | |
| -103.8% | -39.2% | -88.4% | -42.4% | -217.4% | -215.1% | -212.5% | -544.2% | -232.0% | -1,433.3% | -3,146.4% | -2,515.2% |
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.